Assenagon Asset Management
ARRY

Assenagon Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Assenagon Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-888,960
Closed -$41.2M – 1183
2019
Q2 		$41.2M Buy
+888,960
New +$25M 0.31% 64

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Assenagon Asset Management's ARRY Position: Q3 2019 in Review

Assenagon Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 888,960 shares — an estimated $41.2M sold.

Assenagon Asset Management first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $41.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Assenagon Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 888,960 Array Biopharma Inc shares in Q3 2019, an estimated $41.2M.
  • Assenagon Asset Management first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Assenagon Asset Management's Array Biopharma Inc position peaked at $41.2M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Assenagon Asset Management's 13F filing for Q3 2019, filed 16 Oct 2019.